SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Implansens
Implansens Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Implansens Spółka z Ograniczoną Odpowiedzialnością
Implansens Spółka z Ograniczoną Odpowiedzialnością (KRS 0000722858, NIP 9671410563) is a Polish company, headquartered in Bydgoszcz, Kujawsko-Pomorskie voivodeship. IMPLANSENS operates in: Specialist medical practice activities (PKD 86.22.Z). Industry: Healthcare. The company has been listed in the National Court Register since March 9, 2018.
Entity dissolved
The data shown reflects the last known state before removal.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
86.22.ZSpecialist medical practice activities
Other activities
Archived data - last known state
Status as of the last registry entry
Founded
March 9, 2018
8 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
BYDGOSZCZ
KUJAWSKO-POMORSKIE
Primary PKD
86.22.Z
Specialist medical practice activities
Share capital
300.0 K PLN
100 shares total
Shareholders
2
shareholders
Board
N/A
Filed years
N/A
Registry entries
40
latest: January 2, 2026
Risk signals
No KPI data - financial statements and valuation are unavailable for this company.
Rate business credibility - Implansens.
No ratings

News
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the first in the world and the first in Poland accredited longevity-medicine educational programme for doctors. Accreditation by the Polish Medical Chamber; scientific partner: the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.

Explainer
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of medical-imaging centre networks (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. The company was founded in 2005, listed on the WSE since 2011. It operates under the Voxel-Diagnostic brand at several dozen locations across Poland. A two-member management board, a five-member supervisory board.
Latest reporting year
2024
Available years
7
Filing entries
0
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
Yes - IMPLANSENS's majority owner is KAŹMIERCZAK I PARTNERZY LEKARZE SPÓŁKA PARTNERSKA.
20 historical registry entries for Implansens
Change in Section 1 (basic data)
BY.XIII NS-REJ.KRS/7306/24/220/ADE
Filing documents submitted (3 documents)
Company name change, Governance body name change, Representation rule change, Dissolution, Board change, Shareholder change, Change in Section 6 (liquidation, bankruptcy or dissolution)
BY.XIII NS-REJ.KRS/11453/25/307
Company name change, Board change, Change in Section 2 (management and representation), Change in Section 6 (liquidation, bankruptcy or dissolution)
BY.XIII NS-REJ.KRS/15416/25/510
Change in Section 1 (basic data)
BY.XIII NS-REJ.KRS/15416/25/510/ADE
Competing companies or those operating in the same market segment as Implansens (in Bydgoszcz, industry: Healthcare).
WŁOCŁAWEK· Healthcare
Revenue 2024: 184.4 M PLN
BYDGOSZCZ· Healthcare
Revenue 2024: 106.7 M PLN
BYDGOSZCZ· Healthcare
Revenue 2024: 22.3 M PLN
BYDGOSZCZ· Healthcare
Revenue 2024: 11.8 M PLN
BRODNICA· Healthcare
Revenue 2024: 9.4 M PLN
BYDGOSZCZ· Healthcare
Revenue 2023: 9.0 M PLN